Literature DB >> 14605372

Evidence for ozone formation in human atherosclerotic arteries.

Paul Wentworth1, Jorge Nieva, Cindy Takeuchi, Roger Galve, Anita D Wentworth, Ralph B Dilley, Giacomo A DeLaria, Alan Saven, Bernard M Babior, Kim D Janda, Albert Eschenmoser, Richard A Lerner.   

Abstract

Here, we report evidence for the production of ozone in human disease. Signature products unique to cholesterol ozonolysis are present within atherosclerotic tissue at the time of carotid endarterectomy, suggesting that ozone production occurred during lesion development. Furthermore, advanced atherosclerotic plaques generate ozone when the leukocytes within the diseased arteries are activated in vitro. The steroids produced by cholesterol ozonolysis cause effects that are thought to be critical to the pathogenesis of atherosclerosis, including cytotoxicity, lipid-loading in macrophages, and deformation of the apolipoprotein B-100 secondary structure. We propose the trivial designation "atheronals" for this previously unrecognized class of steroids.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605372     DOI: 10.1126/science.1089525

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  51 in total

1.  Formation of cholesterol ozonolysis products in vitro and in vivo through a myeloperoxidase-dependent pathway.

Authors:  Susumu Tomono; Noriyuki Miyoshi; Hidemi Shiokawa; Tomoe Iwabuchi; Yasuaki Aratani; Tatsuya Higashi; Haruo Nukaya; Hiroshi Ohshima
Journal:  J Lipid Res       Date:  2010-10-04       Impact factor: 5.922

Review 2.  Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids.

Authors:  Jean Cadet; Steffen Loft; Ryszard Olinski; Mark D Evans; Karol Bialkowski; J Richard Wagner; Peter C Dedon; Peter Møller; Marc M Greenberg; Marcus S Cooke
Journal:  Free Radic Res       Date:  2012-02-22

3.  Coxibs and cardiovascular risk.

Authors:  Syed A H Zaidi
Journal:  CMAJ       Date:  2005-10-11       Impact factor: 8.262

Review 4.  Cholesterol, reactive oxygen species, and the formation of biologically active mediators.

Authors:  Robert C Murphy; Kyle M Johnson
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

5.  The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation.

Authors:  Sarah J Siegel; Jan Bieschke; Evan T Powers; Jeffery W Kelly
Journal:  Biochemistry       Date:  2007-02-13       Impact factor: 3.162

6.  Site-specific modification of Alzheimer's peptides by cholesterol oxidation products enhances aggregation energetics and neurotoxicity.

Authors:  Kenji Usui; John D Hulleman; Johan F Paulsson; Sarah J Siegel; Evan T Powers; Jeffery W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

7.  Adduction of cholesterol 5,6-secosterol aldehyde to membrane-bound myelin basic protein exposes an immunodominant epitope.

Authors:  Natalie K Cygan; Johanna C Scheinost; Terry D Butters; Paul Wentworth
Journal:  Biochemistry       Date:  2011-02-28       Impact factor: 3.162

8.  Cholesterol secosterol aldehydes induce amyloidogenesis and dysfunction of wild-type tumor protein p53.

Authors:  Jorge Nieva; Byeong-Doo Song; Joseph K Rogel; David Kujawara; Lawrence Altobel; Alicia Izharrudin; Grant E Boldt; Rajesh K Grover; Anita D Wentworth; Paul Wentworth
Journal:  Chem Biol       Date:  2011-07-29

Review 9.  New views on cellular uptake and trafficking of manufactured nanoparticles.

Authors:  Lennart Treuel; Xiue Jiang; Gerd Ulrich Nienhaus
Journal:  J R Soc Interface       Date:  2013-02-20       Impact factor: 4.118

Review 10.  Natural compounds may open new routes to treatment of amyloid diseases.

Authors:  Jan Bieschke
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.